HempNewsBreaks

FridayMay 06, 2022 1:21 pm

HempNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Expanding into Live Resin Vapes Segment to Capitalize on Growing Market

Red White & Bloom (CSE: RWB) (OTCQX: RWBYF) recently announced the rollout of Platinum Vape(TM) (“PV”) Live Resin in Michigan, fulfilling its promise to introduce a steady stream of new products and consumption options to satisfy demand in the state. “The debut marks RWB’s line expansion into the higher-margin live resin vapes segment and also represents its inaugural product in Michigan beyond the popular distillate vape products. The company is committed to releasing many more products in the future,” a recent article reads. “Red White & Bloom expects PV Live Resin to become popular with consumers owing to the trust…

Continue Reading

FridayApr 29, 2022 2:43 pm

HempNewsBreaks – Hero Technologies Inc. (HENC) Focused on Vertical Integration, State Expansion

Hero Technologies (OTC: HENC), a cannabis company working toward a vertically integrated business model, has plans to expand into two states that have legalized cannabis — Colorado and Massachusetts. Cannabis genetic engineering, farmland for medical and recreational cannabis cultivation, production licenses, distribution licenses, consumer packaging, retail operations and dispensaries are all part of HENC’s strategic multistate model. The company owns a majority stake in BlackBox Systems and Technologies LLC. BlackBox is an aeroponic cannabis cultivation system that provides optimal growing conditions to enhance photosynthesis and cultivation of large flowering plants, creating increased harvest efficiencies. A recent article discussing the company’s…

Continue Reading

ThursdayApr 28, 2022 3:03 pm

HempNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Continues to Unlock Capabilities of Revolutionary DehydraTECH(TM) Platform

Lexaria Bioscience Corp. (NASDAQ: LEXX) is aware of the need to continuously improve its understanding of the capabilities and potential applications of its patented DehydraTECH(TM) drug delivery technology. This informs its long-held commitment to its applied research and development (“R&D”) programs. “So far, the company’s research journey has involved a series of controlled and well-designed in vitro preclinical testing and in vivo animal and human clinical studies…. Still, Lexaria is unrelenting in its pursuit of comprehensive datasets that would answer many questions the company expects to face from potential commercial partners or regulators and is, in fact, expanding its research.…

Continue Reading

FridayApr 22, 2022 2:26 pm

HempNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Well Positioned for Opportunity

Flora Growth Corp. (NASDAQ: FLGC) has expanded its portfolio, which spans a range of verticals and diverse revenue streams, with growth largely driven through mergers and acquisitions (“M&As”). With M&As defining its 2021 calendar year, Flora Growth capitalized on global trends, which saw over 63,000 worldwide M&A transactions completed across all industries and sectors as companies sought new avenues for growth amid the pandemic, rising inflation and disrupted supply chains. With two recent acquisitions, Flora Growth “was able to add an estimated $35 million in revenues and $7 million EBITDA. For comparison, back in 2020, the company’s acquisitions generated $28…

Continue Reading

WednesdayApr 20, 2022 1:58 pm

HempNewsBreaks – Hero Technologies Inc. (HENC) Pursuing Diversification, Increased Share in Booming Colorado Market

Hero Technologies (OTC: HENC) anticipates expanding into the booming Colorado cannabis market via cultivation and dispensary operations through its wholly owned subsidiary, Mile High Green LLC. “Cannabis sales in the state broke another record last year, topping $2.22 billion in products sold, according to the Colorado Department of Revenue (https://cnw.fm/SFXzA). This figure ‘eclipses’ 2020 sales reaching upwards of $2.1 billion, which set a previous record,” a recent article reads. “Hero Technologies announced the formation of Mile High Green in March of last year, stating that the purpose of the subsidiary was to seek cannabis, land purchase and strategic acquisition opportunities in…

Continue Reading

MondayApr 18, 2022 2:37 pm

HempNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Expanding Rare Cannabinoid Manufacturing Scale

InMed Pharmaceuticals (NASDAQ: INM), a rare cannabinoid drug developer, is expanding its product manufacturing scale, thanks largely to the acquisition of consumer-focused rare cannabinoids manufacturer BayMedica last year. “InMed’s most-recent Q2 financial statement reported revenues of $0.3 million from commercial sales of cannabichromene (‘CBC’) to the health and wellness market following the BayMedica acquisition. Since January, the company has also been selling cannabicitran (‘CBT’) to the health and wellness market on a B2B basis,” a recent article reads. “The company’s forward-looking focus on bringing new cannabinoid products to commercial scale anticipates scales of cannabidivarin (‘CBDV’) and tetrahydrocannabivarin (‘THCV’) in the…

Continue Reading

MondayApr 18, 2022 1:33 pm

HempNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) on ‘Solid Ground in 2022 and Beyond’

Red White & Bloom (CSE: RWB) (OTCQX: RWBYF), a company positioning itself to be one of the top three multistate operators in the United States in cannabis and hemp-derived product lines, has adopted a strategy anchored in operating a house of brands as it anticipates the commoditization of the cannabis market. “This is going to be a commoditized market, and our strategy is such that we are going to stand on our brands going forward. We just need to fortify what we are doing in the markets that we are in right now,” a recent article quotes RWB CEO Brad…

Continue Reading

MondayApr 11, 2022 3:12 pm

HempNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Taking Diverse Product Portfolio to New Markets

Flora Growth Corp. (NASDAQ: FLGC) recently announced the successful import of Mambe CBD-containing food and beverage products into the United States from Colombia. The move capitalized on a new law signed by Colombian President Ivan Duque, which provides the necessary regulatory framework for cannabis product use and export. “Our team anticipated this regulatory update and has been laying the necessary foundation to expand this new supply chain pathway allowing Flora to quickly bring our diverse product portfolio and low-cost cannabis inputs to new high-growth international markets,” a recent article quotes Flora Growth CEO Luis Merchan as saying. Flora Growth also…

Continue Reading

FridayApr 08, 2022 3:50 pm

HempNewsBreaks – Hero Technologies Inc. (HENC) Focusing on Expansion of Current Operations, Future Industry Growth

Hero Technologies (OTC: HENC) has made key acquisitions and investments that have played an essential role in its strategic business plan and operations. During a recent episode of the Bell2Bell Podcast hosted by Stuart Smith, company CEO Gina Serkasevich discussed HENC’s careful expansion moves. “In 2020, ‘both Highly Relaxing and the assets of V Brokers, under Veteran Hemp Co., were acquired,’ said Serkasevich. ‘Both of these entities gave Hero a foot in the door to establish itself as a cannabis player. Since then, our biggest advancement was becoming a majority stakeholder in BlackBox Systems and Technologies,’” a recent article reads.…

Continue Reading

FridayApr 08, 2022 2:35 pm

HempNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Hopes to Demonstrate DehydraTECH’s Superior Performance in Ongoing Epilepsy Research Program

Lexaria Bioscience Corp. (NASDAQ: LEXX) recently announced the beginning of the first phase of its epilepsy research program, EPIL-A21-1. “The research program will assess the seizure-inhibiting activity of cannabidiol (‘CBD’) administered via the company’s proprietary DehydraTECH(TM) technology, compared to the only FDA-approved CBD-based seizure medication…. The EPIL-A21-1 research program contains two main studies to be performed in rodents following the first phase – a pilot animal model that has already begun. The main studies are slated to commence in May/June and involve an acute seizure model induced by electrical stimulation and chemically induced seizure models,” a recent article reads. “Using…

Continue Reading